Second Vir-GSK monoclonal antibody to enter Phase 1/2 COVID-19 trials Vir Biotechnology and GSK will evaluate VIR-7832 in the early treatment of COVID-19 in a Phase 1b/2a trial starting in the first quarter of this year.
Preclinical data suggests VIR-7832, a neutralising COVID-19 antibody, has two distinguishing properties: an enhanced ability to clear infected cells and the potential to enhance virus-specific T cell function, which could help treat and/or prevent COVID-19 infection.
California’s Vir Biotechnology and GSK entered into a coronavirus collaboration in April 2020: using Vir’s proprietary monoclonal antibody platform tech to identify new and existing anti-viral antibodies for use against the COVID-19 pandemic. VIR-7832 is the second monoclonal antibody from the collaboration.
Image: Alexander Forryan
New research has unlocked the mystery of how the Galápagos Islands, a rocky, volcanic outcrop, with only modest rainfall and vegetation, is able to sustain its unique wildlife habitats.
The Galápagos archipelago, rising from the eastern equatorial Pacific Ocean some 900 kilometres off the South American mainland, is an iconic and globally significant biological hotspot. The islands are renowned for their unique wealth of endemic species, which inspired Charles Darwin’s theory of evolution and today underpins one of the largest UNESCO World Heritage Sites and Marine Reserves on Earth.
Scientists have known for decades that the regional ecosystem is sustained by upwelling of cool, nutrient-rich deep waters, which fuel the growth of the phytoplankton upon which the entire ecosystem thrives.
Las nuevas alternativas de tratamiento para enfrentar el covid-19 elmostrador.cl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elmostrador.cl Daily Mail and Mail on Sunday newspapers.
Prueban una proteína para combatir el Covid-19 - El Diario de Yucatán yucatan.com.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yucatan.com.mx Daily Mail and Mail on Sunday newspapers.